Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine

被引:31
|
作者
Viennois, Emilie [1 ,2 ]
Zhao, Yuan [1 ,3 ]
Merlin, Didier [1 ,2 ]
机构
[1] Georgia State Univ, Inst Biomed Sci, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA
[2] Atlanta Vet Affairs Med Ctr, Decatur, GA USA
[3] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China
基金
美国国家卫生研究院;
关键词
IBD; biomarkers; signature; C-REACTIVE PROTEIN; GELATINASE-ASSOCIATED LIPOCALIN; ACTIVE ULCERATIVE-COLITIS; FECAL CALPROTECTIN; CROHNS-DISEASE; CIRCULATING MICRORNA; EXPRESSION PROFILES; NONINVASIVE MARKER; SURROGATE MARKERS; ACTIVITY INDEX;
D O I
10.1097/MIB.0000000000000444
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of biological and morphological tests. The current method of diagnostic remains a critical challenge for physicians in part due to their invasiveness and also for their limitations in term of diagnosis, prognosis, disease activity and severity assessment, and therapeutic outcomes. Laboratory biomarkers can be used in the diagnosis and management of IBD, but none of them has been proven to be ideal. Increasing efforts are being made to discover new biomarkers that can discriminate between the types of IBD, predict future responses to treatment, and aid in differential diagnosis, treatment planning, and prognosis prediction. This review addresses the potential for current biomarkers and the emergence of the concept of biomarker signatures in IBD diagnostic and personalized medicine.
引用
收藏
页码:2467 / 2474
页数:8
相关论文
共 50 条
  • [1] Inflammatory bowel disease: towards a personalized medicine
    Flamant, Mathurin
    Roblin, Xavier
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11 : 1 - 15
  • [2] Treatments of inflammatory bowel disease toward personalized medicine
    Ki-Uk Kim
    Jisu Kim
    Wan-Hoon Kim
    Hyeyoung Min
    Chang Hwan Choi
    Archives of Pharmacal Research, 2021, 44 : 293 - 309
  • [3] Personalized medicine in inflammatory bowel disease: Perspectives on Asia
    Park, Su Hyun
    Park, Sang Hyoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (08) : 1434 - 1445
  • [4] Inflammatory Bowel Disease-the prototype for personalized medicine
    McGovern, Dermot
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (09) : 2432 - 2432
  • [5] Treatments of inflammatory bowel disease toward personalized medicine
    Kim, Ki-Uk
    Kim, Jisu
    Kim, Wan-Hoon
    Min, Hyeyoung
    Choi, Chang Hwan
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (03) : 293 - 309
  • [6] Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.
    Baldan-Martin, M.
    Azkargorta, M.
    Aransay, A. M.
    Gil-Redondo, R.
    Moreno-Indias, I.
    Iloro, I.
    Soleto, I.
    Orejudo, M.
    Ramirez, C.
    Lucendo, A. J.
    Rodriguez Gutierrez, C.
    Gutierrez, A.
    Martin Arranz, E.
    Bujanda, L.
    Rodriguez-Lago, I.
    Riestra, S.
    Iglesias-Flores, E.
    Bermejo, F.
    Van Domselaar, M.
    Garcia, M. J.
    Fernandez-Salazar, L.
    Garcia-Alonso, J. F.
    Calvet, X.
    Torrealba, L.
    Baston Rey, I.
    Pallares, H.
    Ber, Y.
    Carnerero, E. L.
    Casanova, M. J.
    Millet, O.
    Elortza, F.
    Mato, J. M.
    Tinahones, F. J.
    Chaparro, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I114 - I116
  • [7] Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
    Mosli, Mahmoud H.
    Sandborn, William J.
    Kim, Richard B.
    Khanna, Reena
    Al-Judaibi, Bandar
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (07): : 994 - 1004
  • [8] Novel Biomarkers in Cardiovascular Disease: Research Tools or Ready for Personalized Medicine?
    Stratz, Christian
    Amann, Michael
    Berg, David D.
    Morrow, David A.
    Neumann, Franz-Josef
    Hochholzer, Willibald
    CARDIOLOGY IN REVIEW, 2012, 20 (03) : 111 - 117
  • [9] Molecular pathogenesis of inflammatory bowel disease:: Genotypes, phenotypes and personalized medicine
    Goyette, Philippe
    Labbe, Catherine
    Trinh, Truc T.
    Xavier, Ramnik J.
    Rioux, John D.
    ANNALS OF MEDICINE, 2007, 39 (03) : 177 - 199
  • [10] Immune profiles of Inflammatory Bowel Disease and Spondyloarthritis call for personalized medicine
    Veltkamp, S.
    van Gaalen, F. A.
    Samsom, J. N.
    van der Meulen-de Jong, A. E.
    Voorneveld, P. W.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i550 - i551